Real World Evidence Solutions Market: Reluctance to Rely on Real-World Studies
The global real-world evidence market is projected to reach USD 1,348.1 million by 2023 from USD 689.9 million in 2018, at a CAGR of 14.3% during the forecast period.
The growth of real-world evidence market is majorly driven by the rising geriatric population (and the subsequent increase in the prevalence of chronic diseases), shift from volume- to value-based care, and delays in drug...
Real World Evidence Market | North America to Dominate the Market
Real-world evidence is the clinical
evidence regarding the usage and potential benefits or risks of a medical
product derived from the analysis of real-world data. Real-world data (RWD) is defined
as data derived from a number of sources that are associated with outcomes in a
heterogeneous patient population in real-world settings.
According
to MarketsandMarkets – [157 Pages Report] The global...
Real World Evidence Market: Rising Focus on End-to-End RWE Services
[157 Pages Report] Real-world evidence is the clinical evidence regarding the usage and potential benefits or risks of a medical product derived from the analysis of real-world data. Real-world data (RWD) is defined as data derived from a number of sources that are associated with outcomes in a heterogeneous patient population in real-world settings.
The global real-world evidence...